Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Leiner Plans Suit Against Dr. Reddy’s, Expects Delay Restarting OTC Business

This article was originally published in The Tan Sheet

Executive Summary

Leiner Health Products' restart of its U.S. OTC operations could be delayed due to the loss of an exclusive ingredient supply contract with Dr. Reddy's Laboratories, the Carson, Calif.-based firm says

You may also be interested in...



Leiner Files For Chapter 11 Protection, Explores Selling Business

Leiner Health Products' shutdown of its U.S. OTC operations a year ago forced the firm to seek Chapter 11 bankruptcy protection and explore selling its U.S. business

Leiner Files For Chapter 11 Protection, Explores Selling Business

Leiner Health Products' shutdown of its U.S. OTC operations a year ago forced the firm to seek Chapter 11 bankruptcy protection and explore selling its U.S. business

Plethico’s Natrol Acquisition Reflects Growing Indian Supplement Investment

Plethico Pharmaceuticals' $80.8 million acquisition of Natrol could be a bellwether of Indian firms' interest in growing their presence in the U.S. supplement market

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS100664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel